Drugs / DR-0201
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06008652 | Nov 2023 → Jul 2024 | — | Dren Bio | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DR-0201 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06008652 ↗ |
| Route | Intravenous | “IV administered DR-0201” NCT06008652 ↗ |